HOME › DRUGS › RUFINAMIDE
ACTIVE SUBSTANCE / INN

RUFINAMIDE

Brand name(s): RUFINAMIDE, Inovelon, BANZEL
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
Epilepsy
NDA021911
ACTIVE SUBSTANCE
Rufinamide
REGULATORS
FDA · EMA
SPONSORS / MAH
BIONPHARMA, Eisai GmbH, EISAI INC
TOTAL APPLICATIONS
4
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
RUFINAMIDEANDA211388BIONPHARMAPrescription
BANZELNDA201367EISAI INCPrescription
BANZELNDA021911EISAI INCDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
InovelonEisai GmbHAuthorised16/01/2007Epilepsy

FULL INTELLIGENCE ON RUFINAMIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →